This intriguing finding was further validated in the PC3 and DU145 cell lines (Fig. 5F).Considering the evident association between RRM2 expression at the translational level and clinical outcomes, it can be inferred that this gene is notably more abundant in docetaxel-resistant prostate cancer tissues as opposed to sensitive tissues. The gene discussed is RRM2; the disease is prostate carcinoma.